Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Bernstein SocGen Group Reinstates Sonova Holding AG (SOON:SW) (SONVY) at Market Perform
-
Bernstein SocGen Group Reinstates Demant A/S (DEMANT:DC) (WILYY) at Market Perform
-
Bernstein SocGen Group Reinstates Carl Zeiss Meditec AG (AFX:GR) (CZMWY) at Outperform
-
Bernstein SocGen Group Reinstates Alcon Inc. (ALC:SW) (ALC) at Outperform
-
Bernstein SocGen Group Reinstates Straumann Holding AG (STMN:SW) (SAUHF) at Outperform
-
Gucci's pick of Demna as new design chief unsettles Kering investors
-
Frequency Electronics, Inc. Announces Third Quarter and Fiscal Year 2025 Financial Results
-
Analyst explains why Adobe stock is down despite solid earnings report
-
Kering appoints Demna as Gucci's artistic director
-
'Quality for sale': Buy the pullback in Netflix stock, Bernstein says
-
Bernstein SocGen on CIGNA (CI) after new COO is named
-
Bernstein: 'Lip-Bu Brings Immediate Credibility to Intel (INTC); We Like Him'
-
Bernstein: 'Airbnb Inc. (ABNB) Remains Our Preferred Pick in Online Travel'
-
Bernstein Expecting 'Another Year of Beats and Raises' for Adidas AG (ADS:GR) (ADDYY)
-
StandardAero Inc (SARO) PT Raised to $35 at Bernstein; 'Strong 2024 Finish; Upside Expected in 2025'
-
Bernstein on Quanta Services (PWR): 'Quality on Sale'
-
BeiGene Ltd. (ONC) PT Raised to $259 at Bernstein After 'Asset and Market Model Updates'
-
Bernstein on Netflix (NFLX): 'Quality for Sale'
-
SentinelOne Inc (S) PT Lowered to $27 at Bernstein SocGen Group
-
MarcumAsia Co-Chair Drew Bernstein to Lead Panel on Outlook for Asian IPOs in 2025 at the Roth Capital Conference
-
Lieff Cabraser Files Lawsuit Stemming From Deadly Medical Experimentation On Cancer Patients
-
Bernstein SocGen Group Reiterates Outperform Rating on Elis SA, new European Midcap top pick
-
Intel jumps nearly 15% as investors cheer appointment of new CEO Tan
-
Adobe (ADBE) PT Lowered to $525 at Bernstein SocGen Group
-
Analysts weigh inflation and turnaround efforts ahead of Dollar General’s earnings
-
This French stock is ‘uniquely’ well-placed in the food sector, Bernstein says
-
North America coffee industry seeks answers amid trade war
-
SentinelOne Q4 earnings preview: Analysts share insights ahead of the print
-
Bernstein on US Restaurants: 'Which Companies Can Scale?'
-
Bernstein: 'We Continue to See the Most Compelling Opportunity In Ryanair (RYA:ID) (RYAAY)'
-
Bernstein on US Autos: 'Bright Spots Overshadowed by Tariffs'
-
Bernstein on Stitch Fix, Inc. (SFIX): 'Sewing Together a Recovery'
-
Kanzhun Ltd. (BZ) PT Raised to $18 at Bernstein; 'Q4 Results In-Line, but This Was All About AI'
-
Bernstein SocGen Group Reiterates Outperform Rating on Gilead Sciences (GILD)
-
Bernstein: 'Eaton Corporation (ETN) Positioning for Sustained Growth Mode; We Remain Buyers'
-
CHARLOTTE TILBURY LANDS AT AMERICAN LUXURY BEAUTY RETAILER BLUEMERCURY
-
Shares in Zara owner Inditex tumble as slowing growth startles investors
-
Frequency Electronics Announces Third Quarter Fiscal 2025 Financial Results Conference Call: Thursday, March 13, 2025, at 4:30 PM ET
-
This food stock 'has significant upside from here', analyst says
-
Bernstein Reiterates Outperform on Beam Therapeutics Inc (BEAM) Amid Positive AATD Data
-
Bernstein Sees DoorDash Inc. (DASH) as a 'Core, Long-Term Holding in Internet'
-
Bernstein on Oracle (ORCL): 'Time to Buy Any Weakness'; PT Lowered to $207
-
Bernstein SocGen Group Reiterates Outperform Rating on Atlassian Corporation (TEAM)
-
Bernstein Reiterates Outperform on StandardAero Inc (SARO) Following 'Strong Q4 and a Strong Guide'
-
Bernstein Pitches Buy for Mondelez International (MDLZ), Sees 'Significant Upside'
-
LIFT Summit 2025 Announces Keynote Speakers and Expert Panelists
-
In preparation of Phase II studies, Right Brain Bio signs Manufacturing Agreement with Suven Pharmaceuticals for RB-190 to Target the Root Cause of Parkinson's Disease
-
Magic Software Reports Fourth Quarter and Full Year 2024 Financial Results
-
Analyst says this stock remains attractive despite recent noises'
-
Bernstein on if now is 'a rare discount investment opportunity' to buy ServiceNow shares

